Recent studies by Tomasetti et al. revealed that the risk disparity among different types of cancer is mainly determined by inherent patterns in DNA replication errors rather than environmental factors. In this study we reveal that inherent patterns of DNA mutations plays a similar role in cancer at the molecular level.
Introduction
Cancer is a group of complex diseases marked by abnormal proliferation of cells as well as somatic mutations of genes. A person has a 40.37% lifetime risk of diagnosis and a 20.84% lifetime risk of dying from cancer (cancer.gov, September 24, 2014) . Despite extensive studies, cancer remains a major challenge in the key for understanding the biology of cancer, while cancer gene mutations in individual tumor hold the key for cancer precision medicine.
Despite our successes in discovering cancer genes, the fundamental distinctions between cancer genes and non-cancer genes remain undefined. Studies of the cancer genes repeatedly identify a handful of key biological pathways [3] , yet many genes in the same pathways lacks recurrent mutations despite being functionally related to cancer [1, 3, 4] . Relatedly, many cancer genes mutate only in specific type of cancers, or shows drastically different mutation frequency in different types of cancers. These hint that protein function is not the only determinant of cancer genes. Recent studies by Tomasetti et al. revealed that the prevalence difference among different types of cancer is mainly determined by inherent patterns in DNA replication errors rather than environmental factors [5, 6] . In this study we reveal that inherent patterns of DNA mutations plays a similar role in cancer at the molecular level on cancer genes.
Cancer has been recognized as a process of cellular evolution inside human body [7, 8] . In light of the molecular evolution theory, we propose gene's mutation vulnerability as an independent factor, which together with gene's specific functions, distinguish cancer genes from other genes. Specifically, different genes are of different spontaneous nucleotide mutation rates, different vulnerability to amino acid changes upon nucleotide mutations, and different vulnerability to functional changes upon amino acid mutations. The vulnerability of a cancer related gene to function impairment sets the stage for somatic selection pressure to play its role.
Based on this theory, we hypothesize that cancer genes are more vulnerable to mutations compared to other genes. To test the hypothesis, we quantify the mutation vulnerability (MVI) of a gene based on the coding DNA sequence (CDS), the DNA mutation rate and spectrum, and the genetic table. We discovered that gene MVI differs significantly between cancer genes and non-cancer genes, and also among different types of cancer genes. Further, we show that MVI of a cancer gene is predictive of its overall mutation frequency in cancers. Finally within individual cancer genes, we show that codon level mutation vulnerability is predictive of the observed codon mutation frequency.
Materials and Methods

Mutation vulnerability index
We use a basic probabilistic model to describe the mutation of genes during somatic evolution. Let CDS = N 1 N 2 ...N j ...N L be a coding sequence of length L. We model the probability of nucleotide N j mutating to N j after one round of DNA replication as P (N j |CDS) = θ Nj−1(Nj →N j )Nj+1 , where θ Nj−1(Nj →N j )Nj+1 is the neighbor-dependent single nucleotide mutation rate [9, 10] . Notice that, N j ∈N ={A,C,G,T } θ Nj−1(Nj →N j )Nj+1 = 1 for any given N j . In this study, we only model single nucleotide mutations and ignore in-dels and more complex mutation types. Further we assume the nucleotides mutate independently conditioned on the current CDS, i.e. P (CDS = N 1 N 2 ...N j ...N L |CDS) = L j=1 P (N j |CDS). As a result, the probability of two point mutations happening on a single codon or within a single gene is negligible.
We then define the mutation vulnerability index mvi x for a codon x of trinucleotide N j N j+1 N j+2 as the expected number of nonsynonymous substitution on this codon after one round of DNA replication:
where I(x ; x) is the identity function that takes 1 if and only if two codons x and x are nonsynonymous, while P (x |S) is calculated as P (N j |S) · P (N j+1 |S) · P (N j+2 |S). Notice that I(x ; x) measures the functional consequence of mutations, while P (x |S) measures the mutational biases. In this study, we use a simple identity function I(x ; x) that treats all nonsynonymous mutations as equally non-neutral regardless of the amino acid types and locations in the protein, and similarly treats all synonymous mutations as neutral. M V I for a gene is further defined as the expected number of nonsynonymous substitutions on the CDS after one round of DNA replication, and it is calculated as the summation of codon mvi:
Predictive models and codon importance
Three types of machine learning methods, including logistic regression, random forest, and neural network, are evaluated with 10 fold cross-validation to determine their performances in predicting cancer genes. Random forest and neural network are evaluated here in order to detect the potential contributions of codon interactions to cancer gene status. Specifically, the data were randomly divided into 10 folds, and 10 separate models were each trained with 90% of the data and tested on the remaining 10%. For training of random forest models, the same number of non-cancer genes were randomly sampled to match the size of the cancer genes in the training set, and 5000 trees were grown. For each machine learning method, five set of models were built using different feature variables: Len, only the CDS length is used in building the models; mvi, only the precomputed average codon mvi for each gene is used; Len + mvi, both CDS length and average codon mvi are used; codon, the 64 codon frequencies for a gene are used; Len + codon, both CDS length and the 64 codon frequencies (normalized by length) are used.
Two measures were used to quantify the importance of each type of codon (feature) in predicting cancer genes: 1) the coefficients of the codon frequency variables in the generalized linear model with logit link function; 2) the mean decrease of classification accuracy associated with each codon in the random forest model.
Mutation rate and spectrum
Due to the chemical properties of DNA as well as cell's DNA repair machinery, nucleotide's mutation rate and spectrum vary depending on the identity of the nucleotide, the neighboring nucleotides, as well as the local genomic context [10] [11] [12] . For cancer genes, both germline and somatic mutations play important roles. The somatic mutation spectrum can be different from the germline mutations depending the carcinogen that drives the mutations [13, 14] , while the overall mutation rate in detectable cancer tissues are generally higher than non-cancer cells [15] . However, the somatic mutation rate and spectrum vary depending on the carcinogen, cancer type, and cancer stage. It is hard to obtain a universal somatic mutation spectrum to model all cancer genes together. Here we use the germline mutation rate and spectrum to model all cancer gene mutations. We believe it is a good model for the germline cancer gene mutations, as well as the somatic cancer gene mutations at the dormant or initiation stage of cancer. The germline mutation rate has been estimated based on mutations of pseudogenes to be around 2.5 × 10 −8 [16] . The neighbor-dependent mutation rates are then obtained by adjusting the neighbor-dependent mutation spectrum [10] with this mutation rate. The full mutation rate rates estimated on human pseudogenes [10] . We then systematically studied the association between gene's mutation vulnerability and its cancer gene status.
We observed a global increase in mutation vulnerability of known cancer genes compare to other genes (Fig. 3A) . The average gene level MVI of cancer genes is 48.8% higher compare to that of non-cancer genes (p-value 6.9 × 10 −32 , based on two sample T-test on the log transformed MVIs). We dissected the cancer genes based on whether somatic mutation or germline mutations are observed for them ( Fig. 3B-D Test, z = 4.20, p-value = 2.7 × 10 −5 ). With these, we suggest that both CDS length and codon usage are biologically associated with cancer genes, with CDS length being the main contributor to the association.
The predictive power of codon usage on cancer genes
The mutation vulnerability index calculated based on Equation 2 has two limitations. First, it relies on the germline nucleotide mutation spectrum, which was derived based on pseudogenes [10] . Second, it utilizes a naive model for amino acid mutation effect such that all nonsynonymous mutations lead to protein function impairment. One way to overcome these limitations is to use machine learning and directly model the relationship between the codon usage and cancer gene status. We refer to the learned probability from such data-driven model as the learned MVI as compared to the precomputed MVI from Equation2.
Using Similar results are obtained for random forest with mean decrease of classification accuracy as codon importance measure.
The 5 most importance codons are TCG, CGA, CGT, CCG, and ACG. Notice they all contain CpG di-nucleotide, which are known to be associated with high mutation rates due to methylation. Among these five codons, four have significantly higher codon usage in cancer genes compared to non-cancer genes (Fig. 4D) , with 21%, 13%, 15%, and 22% higher frequencies in cancer genes for codons TCG, CGA, CGT, CCG respectively.
It is worth noting that across human CDSs, there is a global negative association between the codon's mutation vulnerability and the codon usage (Pearson correlation R = -0.37, p-value = 0.0026, or R = -0.43, p-value = 0.00048 after removing the stop codons, Supp. Fig. 1 ). This is consistent with the mutational bias theory of codon usage biases, which states that the codons that are easily mutated at the nucleotide level to other codons will end up having low frequency.
The variation of MVI among cancer genes is associated with their mutation frequency
While we observed that gene MVI differs between cancer genes and non-cancer genes ( Fig. 3-4) , we also notice large variation of MVI among cancer genes themselves (Fig. 3) . Are the MVI differences between two cancer genes of any biological significance?
We believe MVI together with gene's function determine the probability that a gene is observed mutated in cancer. There are two predictions from this: first, MVI will impact a gene's cancer gene status; second, MVI will impact the mutation frequency of cancer genes. We have evaluated and confirmed the first prediction. To validate the second prediction, we estimate each cancer gene's mutation frequency in cancer samples based on the mutation data in COS-MIC. Notice that not all samples in COSMIC were subjected to full genome sequencing, hence the estimation can be conservative and inaccurate. Despite this, we observed significant association between cancer genes' MVIs and their mutation frequencies (Fig. 5) . There are significant positive associations between precomputed MVIs and mutation frequencies for tumor suppressor genes (Spearman rank correlations 0.687, p-value 1. Intra-gene codon mutation frequency and codon mutation vulnerability are associated
Cancer is a process of somatic evolution. If somatic selection pressure is uniformly positive for all amino acid mutations in cancer proteins, then the spontaneous mutation rate of an amino acid decides its mutation frequency in cancer, and the spontaneous mutation rate of a cancer protein decides the cancer gene's mutation frequency in cancer. We have studied the gene level mutation frequency in the previous section, and here we study the codon level mutation rate.
For each of the 541 cancer genes with mutation data, we determine if the observed mutation frequency of the codons (along the CDS) are correlated with precomputed codon mutation vulnerability (mvi ). Positive linear correlations are observed for 89% (482) of the genes, among which 71% (342) are significant at p-value cutoff 0.01, and 52% (253) remain significant after BenjaminiHochberg correction. By contrast, among the 59 genes with negative correlations between mvi and observed codon mutation frequency, none are significant at p-value cutoff 0.01 (Fig. 6A) . The codon mvi-codon mutation frequency correlation is on average stronger for tumor suppressor genes compared to oncogenes (p-value 1.0×10 −8 , Mann-Whitney test on the ranks of p-values for codon mutation frequency-mvi correlation). 97% of the tumor suppressor genes has positive codon mvi-mutation frequency correlation, 81% among which are significant at p-value level 0.01, while only 87% of oncogenes has positive mvi-mutation frequency correlation, 67% among which being significant. We visualized RB1 and PHF6 as examples to further understand the codon mvi-codon mutation frequency relationship. By plotting the predicted codon mvi and observed codon mutation frequency spectra as mirror images (Fig. 6B) , we find that mutation vulnerability explains a significant portion of the mutation hot spots. Majority of mutation hot spots have high mutation vulnerability, although many codons with high mvi are not highly mutated, suggesting that high mutation vulnerability is a precondition for high mutation frequency. These corroborate with previous findings and support the important roles of mutation vulnerability on cancer gene mutation.
Discussion
Cancer is a complex genetic [18, 19] and aging disease [20] . Recently big data approach to cancer genomics study is driving an increasingly complete understanding of the genes and pathways underlying cancer development [21] [22] [23] [24] , while at the same time revealing the stochastic nature of cancer due to somatic evolution [7, 8] . Over 500 cancer genes have been identified with recurrent (driver) mutations in cancer samples, yet no cancer gene is found to mutate in all cancers, and no two cancers share the same set of cancer gene mutations.
The specific functions, e.g. biological processes, pathways and protein interactions, of genes are believed to be the reason why some genes are cancer genes while others are not [25] .
In this study, we analyze the mutational aspect of cancer genes. We found that biases in the DNA mutation process, captured by each gene as its mutation vulnerability (MVI), significantly impact the likelihood for a gene to be observed as cancer gene. Compared to non-cancer genes, cancer genes have on average 48.8% higher mutation vulnerability (Fig. 3) , with contributions from both protein length and codon usage. Importantly, among the cancer genes, the ones with higher MVI also have higher mutation frequency in cancer samples (Fig. 5) . This suggests that MVI influences a gene's chance of being a cancer gene in a quantitative manner. Recent studies [5, 6] revealed that the cancer risk disparity among different tissue types is mainly determined by inherent properties of DNA replication errors related to cell types rather than environmental factors. In this study we reveal that inherent patterns of DNA mutations may play a similar role at the molecular level.
At the codon level, we observe that majority of highly mutated codons in cancer genes have high mvi (codon mutation vulnerabilities), while many codons with high predicted mvi are not highly mutated (Fig. 6) . High mutation vulnerability and functional relevance are likely two independent prerequisites for a gene to be cancer gene and for a codon of a cancer gene to mutated in cancer. The mutation vulnerability of genes and codons set the stage for positive selection to play its role in cancer formation [26] . A gene with cancer relevant function but low vulnerability may not show statistically significant mutation frequency to be identifiable as a cancer gene. We suggest that cancer gene should not be viewed as a binary concept but rather a continuum. With more cancer genomes sequences, we will have more power and detect more "weak" cancer genes.
A machine learning approach for predicting cancer gene will help us to understand the key features differentiating cancer gene from other genes, and it may also guide the discovery of new cancer genes and improve the interpretation of cancer genomes in differentiating driver mutations from non-driver mutations.
Existing effort for cancer gene prediction has been focused on utilizing the functional attributes of genes, e.g. molecular functions and signaling pathways, locations and connectivity in the protein-protein interaction network [25, 27] .
Some recent studies also suggested the value of gene expression [25, 26, 28] .
We reveal here that cancer genes can be predicted at a decent performance by precomputed or learned MVIs, both of which are functions of gene's codon frequencies (Fig. 4) . Further improvement of cancer gene prediction will be possible if the protein functions and expression levels are combined with the mutation vulnerabilities of genes.
We note that the mutation vulnerability index is inversely related to concept of mutational robustness in evolutionary biology [29, 30] , which describes the property that an organism's fitness remains unchanged upon mutations. The main feature of MVI is that it captures the spontaneous mutation biases of nucleotides as well as the consequences of the nucleotide mutations. MVI, however, does not accurately model if an amino acid change is functionally neutral to the cell or organism.
There are several limitations in our approach for computing gene's mutation vulnerability. First, we only model single nucleotide mutations. In-dels and rearrangements, which are common for oncogenes, are not considered. Explicit modeling of these mutation types could give us a better mutation vulnerability index for genes. We also only consider the impact of two immediate neighbors on the mutation rate of a nucleotide. Including more neighboring nucleotides as well as the local genomics environment around a gene, e.g. chromatin structure and CG%, could improve the accuracy of MVI. Finally, for the precomputed MVI (Equation 2) non-sense and missense mutations are treated equally, and all missense mutations are viewed the same in terms of their functional impacts.
Ongoing research shows that we can better predict the functional consequences 13 of amino acid changes by incorporating the amino acid conservation patterns and neighboring amino acid sequences [31] [32] [33] . Using these advanced models instead of the naive mutation effect model could lead to a better MVI, improved cancer gene predictions, and increased understanding of cancer genes.
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